## Gene Summary
CYP39A1, or Cytochrome P450 Family 39 Subfamily A Member 1, is a gene encoding an enzyme that belongs to the cytochrome P450 superfamily of enzymes. These enzymes are involved in the oxidation of various substances, including steroids and other xenobiotics. CYP39A1 specifically catalyzes the formation of 24-hydroxycholesterol from cholesterol, which is a critical reaction in the alternate pathway of bile acid synthesis. The expression of CYP39A1 is found predominantly in the liver but is also present in other tissues such as the brain.

## Gene Drugs, Diseases, Phenotypes, and Pathways
CYP39A1 is key in cholesterol metabolism and bile acid biosynthesis. Perturbations in these pathways are associated with various metabolic disorders. While CYP39A1 itself may not be directly linked to specific diseases, the pathways it influences are critical for lipid homeostasis and could indirectly affect conditions like atherosclerosis, gallstone disease, and certain liver disorders. Alterations in cholesterol metabolism can lead to an imbalance in bile acids, thus influencing these conditions.

## Pharmacogenetics
The pharmacogenetics of CYP39A1 are not as well-characterized as those of other cytochrome P450 enzymes that metabolize drugs. Currently, there is limited information on direct associations between CYP39A1 and specific drug responses or adverse drug reactions. As such, its role in drug metabolism is generally considered minor compared to other more prominent enzymes in the P450 family, such as CYP3A4 or CYP2D6. Research into the pharmacogenetics of CYP39A1 might reveal more about its potential roles in modifying drug efficacy or toxicity, particularly in drugs influencing cholesterol and steroid metabolism.